{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:52:37Z","timestamp":1789602757120,"version":"build-2803163510"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>(Auto)immune mediated and cholestatic liver disease (AILD) includes autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Especially AIH is characterized by the presence of autoantibodies and elevated serum immunoglobulins. In rheumatoid arthritis, autoantibodies against post-translational modifications (PTMs) such as citrullination (Cit) and carbamylation (CarP) are used as diagnostic and prognostic markers, respectively. We studied the presence of six anti-PTM antibodies in patients with the three AILDs and non-AILD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Antibodies against six PTMs (malondialdehyde\u2013acetaldehyde adducts (MAA), advanced glycation end-products (AGE), CarP, acetylation (AL), Cit, and nitration (NT)) were tested in sera of patients with AILD (<jats:italic>n<\/jats:italic>\u2009=\u2009106), non-AILD (<jats:italic>n<\/jats:italic>\u2009=\u2009101) and compared with healthy controls (HC) (<jats:italic>n<\/jats:italic>\u2009=\u2009100). Levels and positivity were correlated with clinical and biochemical features in a well-defined cohort of untreated AIH patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Anti-PTM antibodies were more often detectable in sera from AILD patients compared with HCs (anti-MAA: 67.9% vs. 2.0%, anti-AGE: 36.8% vs. 4.0%, anti-CarP: 47.2% vs. 5.0% and anti-AL: 18.9% vs. 5.0%). In untreated AIH, time to complete biochemical response (CBR) was associated with anti-MAA, anti-AGE, anti-CarP and anti-AL antibodies. Significantly more patients with at least three anti-PTM antibodies attained CBR at 12\u2009 months of treatment (13 vs. 3 <jats:italic>p<\/jats:italic>\u2009=\u20090.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Anti-PTM antibodies are frequently present in AILD. The presence of anti-MAA, anti-AGE and anti-CarP antibodies correlates with the presence of AIH within this cohort. In AIH, harboring at least three anti-PTM antibody responses is positively associated with CBR. Determination of anti-PTM antibodies in liver disease may have diagnostic and prognostic value.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1195747","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T09:19:12Z","timestamp":1690276752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment"],"prefix":"10.3389","volume":"10","author":[{"given":"Michelle D.","family":"van den Beukel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E. C.","family":"Stoelinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan J.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stef","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten E.","family":"Tushuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.3748\/wjg.v22.i19.4651","article-title":"Auto immune hepatitis","volume":"22","author":"van Gerven","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gy\u00f6rgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2017.12.001","article-title":"Protein Carbamylation: chemistry, pathophysiological involvement, and biomarkers","volume":"84","author":"Jaisson","year":"2018","journal-title":"Adv Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e002079","DOI":"10.1136\/rmdopen-2021-002079","article-title":"Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations","volume":"8","author":"Monahan","year":"2022","journal-title":"RMD Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/tx9501445","article-title":"Oxidative damage and tyrosine nitration from peroxynitrite","volume":"9","author":"Beckman","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.bbapap.2016.06.007","article-title":"The world of protein acetylation","volume":"1864","author":"Drazic","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1179\/1351000214Y.0000000101","article-title":"Oxidative stress and antioxidant status in patients with autoimmune liver diseases","volume":"20","author":"Kaffe","year":"2015","journal-title":"Redox Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbadis.2004.01.005","article-title":"Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis?","volume":"1689","author":"Pemberton","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF03346408","article-title":"Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantation","volume":"31","author":"Buongiorno","year":"2008","journal-title":"J Endocrinol Investig"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/j.1530-0277.1998.tb03973.x","article-title":"Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant","volume":"22","author":"Thiele","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.05.086","article-title":"Oxidative stress in autoimmune rheumatic diseases","volume":"125","author":"Smallwood","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2036.2005.02686.x","article-title":"Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis","volume":"22","author":"FUSCONI","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/08916930600783348","article-title":"Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis","volume":"39","author":"Montano-Loza","year":"2006","journal-title":"Autoimmunity"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/j.1530-0277.2010.01309.x","article-title":"Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites","volume":"34","author":"Thiele","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0021-9150(98)00153-1","article-title":"Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury","volume":"141","author":"Hill","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of liver, diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"492873","DOI":"10.1155\/2014\/492873","article-title":"Autoantibodies to posttranslational modifications in rheumatoid arthritis","volume":"2014","author":"Burska","year":"2014","journal-title":"Mediat Inflamm"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.cgh.2021.05.024","article-title":"Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1: a landmark analysis","volume":"20","author":"Biewenga","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.jhepr.2020.100094","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1365-2249.2003.02205.x","article-title":"Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA)","volume":"133","author":"KU\u010cERA","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/art.40562","article-title":"Triple positivity for anti-Citrullinated protein autoantibodies, rheumatoid factor, and anti-Carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals","volume":"70","author":"Verheul","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"European Association for the Study of the liver. Electronic address, e.e.e. and L. European Association for the Study of the, EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Galle","year":"2017","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep.27715","article-title":"Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation","volume":"61","author":"Poupon","year":"2015","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","article-title":"Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis","volume":"75","author":"Hisamoto","year":"2016","journal-title":"J Autoimmun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human Cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.cgh.2018.12.035","article-title":"Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis","volume":"17","author":"Pape","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/HEP.0000000000000018","article-title":"Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration","volume":"77","author":"D\u00edaz-Gonz\u00e1lez","year":"2023","journal-title":"Hepatology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1195747\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T09:19:16Z","timestamp":1690276756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1195747\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":45,"alternative-id":["10.3389\/fmed.2023.1195747"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1195747","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"article-number":"1195747"}}